查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1454824

尿路結石管理設備市場：依產品類型、最終用戶、地區：全球產業分析、規模、佔有率、成長、趨勢、預測 2023-2030

Urolithiasis Management Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 187 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究最近發佈了尿路結石管理設備市場的詳細分析，提供了有關市場動態、成長驅動因素/課題和新興趨勢的重要見解。該報告提供了預測 2023 年至 2030 年市場軌蹟的獨家數據和統計數據，為醫療保健行業利益相關者提供了寶貴的觀點。

全球尿路結石治療設備市場預計複合年增長率為 5.1%，從 2023 年的 16 億美元成長到 2030 年底的 22 億美元。

重要見解

  • 尿路結石治療設備市場規模（2023 年估計）：16 億美元
  • 市場預測值（2030年預測）：22億美元
  • 全球市場成長率（2023-2030年複合年增長率）：5.1%
  • 過去的市場成長率（2018-2022年複合年增長率）：4.1%

尿路結石管理設備市場 - 報告範圍：

尿路結石管理設備市場包括各種旨在診斷、治療和預防尿路結石的醫療設備和技術。這些設備包括碎石機、輸尿管鏡、結石取出設備、支架和結石管理耗材。該市場的驅動因素包括尿石症盛行率的不斷上升、微創手術技術的進步以及門診結石管理程序需求的不斷增加。此外，機器人技術和影像模式整合等技術創新正在徹底改變尿石症的治療，為患者提供更安全、更有效的治療選擇。

市場驅動因素：

全球尿路結石管理設備市場主要是由全球尿路結石發生率上升所推動的。久坐的生活方式、飲食習慣和環境因素會導致腎結石的形成，從而推動對先進治療方案的需求。體外震波碎石術（ESWL）和輸尿管鏡檢查等微創手術因其術後併發症較少且恢復時間較短而受到患者的青睞。此外，雷射碎石術的出現和一次性輸尿管鏡的市場發展正在擴大尿石症患者的治療選擇並推動市場成長。

市場限制因素：

儘管市場條件有利，但尿路結石管理設備市場在報銷政策、醫療基礎設施和患者意識方面面臨課題。某些尿路結石手術和設備的報銷不足限制了患者獲得先進治療的機會，特別是在新興市場。此外，衛生基礎設施的差異，特別是在農村和服務不足的地區，阻礙了尿路結石的及時診斷和治療，導致患者的治療效果和治療成本惡化。此外，患者對尿路結石預防策略和治療方案的認識有限，阻礙了早期介入和疾病管理，延長了患者的痛苦和醫療支出。

市場機會：

全球尿路結石管理設備市場已準備好充分利用遠距醫療、數位健康和以患者為中心的護理模式的新興機會。遠距醫療平台和遠端監控技術的廣泛使用使醫療保健提供者能夠為尿石症患者提供及時的諮詢和隨訪，提高治療依從性和結果。此外，行動應用程式和穿戴式裝置等數位健康解決方案可讓患者追蹤症狀、藥物依從性和生活方式的改善，從而促進個人化的疾病管理和預防干預。透過利用科技和病患參與的力量，尿路結石管理設備市場的利害關係人可以優化醫療服務、提高病患滿意度並降低整體醫療成本。

本報告解決的關鍵問題

  • 預計哪些地區將在未來幾年推動尿路結石治療設備市場的成長？
  • 推動尿路結石治療設備和技術採用的關鍵因素是什麼？
  • 不斷發展的治療指南和技術進步將如何影響市場動態？
  • 誰是塑造尿路結石管理設備市場競爭格局的關鍵參與者？
  • 市場參與者採取哪些策略來獲得競爭優勢並擴大市場佔有率？

目錄

第一章執行摘要

第二章市場概況

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
    • 主要趨勢
  • 治療類型生命週期分析
  • 尿路結石治療設備市場：價值鏈
    • 原材料供應商名單
    • 製造商名單
    • 經銷商名單
    • 應用清單
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：對市場的影響
  • 宏觀經濟因素
    • 世界產業展望
    • 世界GDP成長率展望
    • 全球母公司市場概覽
  • 預測變量 - 相關性和影響
  • 監管和技術格局

第三章全球尿路結石治療設備市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
    • 市場容量（單位）預測
    • 市場規模及年成長率
    • 絕對的賺錢機會
  • 市場規模（百萬美元）分析與預測
    • 過去的市場規模分析，2013-2016
    • 目前市場規模預測，2018-2026
  • 全球尿路結石治療設備市場展望：治療類型
    • 簡介/主要發現
    • 2018-2022 年依治療類型劃分的歷史市場規模（百萬美元）和數量（單位）分析
    • 2023-2030 年當前市場規模（百萬美元）和依處理類型劃分的處理量（單位）預測
      • 體外震波碎石術（ESWL）
      • 經皮腎鏡取石術
      • 體內碎石術
      • 其他
  • 市場吸引力分析：治療類型
  • 全球尿路結石治療設備市場展望：產品類型
    • 簡介/主要發現
    • 2018-2022 年依產品類型劃分的歷史市場規模（百萬美元）和數量（單位）分析
    • 2023-2030 年依產品類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
      • 碎石機
      • 輸尿管鏡
  • 市場吸引力分析：產品類型
  • 全球尿路結石治療設備市場前景：最終用戶
    • 簡介/主要發現
    • 2018-2022 年最終用戶過去的市場規模（百萬美元）和數量（單位）分析
    • 當前市場規模（百萬美元）和最終用戶預測的數量（單位），2023-2030 年
      • 醫院和診所
      • 門診手術中心 (ASC)
  • 市場吸引力分析：最終用戶

第四章全球泌尿道結石疾病管理設備市場展望：地區

  • 主要亮點
  • 2018-2022 年依地區歷史市場規模（百萬美元）及成交量（單位）分析
  • 2023-2030 年依地區劃分的當前市場規模（百萬美元）和預測數量（單位）
    • 北美
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：區域

第五章北美尿路結石管理設備市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依治療類型
    • 依產品類型
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 美國
    • 加拿大
  • 2023-2030 年當前市場規模（百萬美元）和依處理類型劃分的處理量（單位）預測
  • 2023-2030 年依產品類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 當前市場規模（百萬美元）和最終用戶預測的數量（單位），2023-2030 年
  • 市場吸引力分析

第六章歐洲泌尿結石疾病管理設備市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和數量（單位）分析
    • 依國家
    • 依治療類型
    • 依產品類型
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 土耳其
    • 歐洲其他地區
  • 2023-2030 年當前市場規模（百萬美元）和依處理類型劃分的處理量（單位）預測
  • 2023-2030 年依產品類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 當前市場規模（百萬美元）和最終用戶預測的數量（單位），2023-2030 年
  • 市場吸引力分析

第七章東亞泌尿結石疾病管理設備市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依治療類型
    • 依產品類型
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 中國
    • 日本
    • 韓國
  • 2023-2030 年當前市場規模（百萬美元）和依處理類型劃分的處理量（單位）預測
  • 2023-2030 年依產品類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 當前市場規模（百萬美元）和最終用戶預測的數量（單位），2023-2030 年
  • 市場吸引力分析

第8章南亞和大洋洲尿石症管理設備市場展望：歷史（2018-2022）和預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依治療類型
    • 依產品類型
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 印度
    • 東南亞
    • 紐西蘭
    • 南亞和大洋洲其他地區
  • 2023-2030 年當前市場規模（百萬美元）和依處理類型劃分的處理量（單位）預測
  • 2023-2030 年依產品類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 當前市場規模（百萬美元）和最終用戶預測的數量（單位），2023-2030 年
  • 市場吸引力分析

第9章拉丁美洲泌尿結石疾病管理設備市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依治療類型
    • 依產品類型
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 2023-2030 年當前市場規模（百萬美元）和依處理類型劃分的處理量（單位）預測
  • 2023-2030 年依產品類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 當前市場規模（百萬美元）和最終用戶預測的數量（單位），2023-2030 年
  • 市場吸引力分析

第10章中東和非洲泌尿道結石疾病管理設備市場展望：歷史（2018-2022）和預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依治療類型
    • 依產品類型
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 海灣合作委員會
    • 埃及
    • 南非
    • 北非
    • 其他中東和非洲
  • 2023-2030 年當前市場規模（百萬美元）和依處理類型劃分的處理量（單位）預測
  • 2023-2030 年依產品類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 當前市場規模（百萬美元）和最終用戶預測的數量（單位），2023-2030 年
  • 市場吸引力分析

第十一章競爭格局

  • 2022 年市場佔有率分析
  • 市場結構
  • 公司簡介（詳細資訊 - 概述、財務、策略、近期發展）
    • Allengers
    • Boston Scientific
    • BD
    • Cook Medical
    • ConMed
    • DirexGroup
    • Dornier MedTech
    • KARL STORZ
    • Potent Optotronic
    • HealthTronics
    • Lumenis
    • Olympus
    • Richard Wolf
    • Siemens Healthcare

第十二章附錄

簡介目錄
Product Code: PMRREP33964

Persistence Market Research has recently released an in-depth analysis of the Urolithiasis Management Devices Market, providing critical insights into market dynamics, growth drivers, challenges, and emerging trends. This report presents exclusive data and statistics forecasting the market's trajectory from 2023 to 2030, offering valuable perspectives for stakeholders in the healthcare industry.

The global urolithiasis management devices market is forecast to expand at a CAGR of 5.1% and thereby increase from a value of US$1.6 Bn in 2023, to US$2.2 Bn by the end of 2030.

Key Insights:

  • Urolithiasis Management Devices Market Size (2023 Estimate): USD 1.6 Billion
  • Projected Market Value (2030 Forecast): US$ 2.2 Billion
  • Global Market Growth Rate (CAGR 2023 to 2030): 5.1%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 4.1%

Urolithiasis Management Devices Market - Report Scope:

The urolithiasis management devices market encompasses a wide range of medical devices and technologies aimed at the diagnosis, treatment, and prevention of urinary tract stones. These devices include lithotripters, ureteroscopes, stone retrieval devices, stents, and stone management consumables. The market is driven by the increasing prevalence of urolithiasis, advancements in minimally invasive surgical techniques, and the growing demand for outpatient stone management procedures. Moreover, technological innovations, such as the integration of robotics and imaging modalities, are revolutionizing urolithiasis treatment, offering patients safer and more effective therapeutic options.

Market Growth Drivers:

The global urolithiasis management devices market is primarily fueled by the rising incidence of urinary tract stones worldwide. Factors such as sedentary lifestyles, dietary habits, and environmental factors contribute to the formation of kidney stones, driving the demand for advanced treatment modalities. Minimally invasive procedures, such as extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy, are preferred by patients due to their reduced post-operative complications and shorter recovery times. Furthermore, the advent of laser lithotripsy and the development of disposable ureteroscopes are expanding the treatment options available to urolithiasis patients, fostering market growth.

Market Restraints:

Despite favorable market conditions, the urolithiasis management devices market faces challenges related to reimbursement policies, healthcare infrastructure, and patient awareness. Inadequate reimbursement for certain urolithiasis procedures and devices limits patient access to advanced treatments, particularly in emerging markets. Moreover, disparities in healthcare infrastructure, particularly in rural and underserved areas, hinder timely diagnosis and treatment of urolithiasis, exacerbating patient outcomes and treatment costs. Furthermore, limited patient awareness about urolithiasis prevention strategies and treatment options impedes early intervention and disease management, prolonging patient suffering and healthcare expenditures.

Market Opportunities:

The global urolithiasis management devices market is poised to capitalize on emerging opportunities in telemedicine, digital health, and patient-centric care models. With the proliferation of telehealth platforms and remote monitoring technologies, healthcare providers can deliver timely consultations and follow-ups to urolithiasis patients, enhancing treatment adherence and outcomes. Moreover, digital health solutions, such as mobile applications and wearable devices, empower patients to track their symptoms, medication adherence, and lifestyle modifications, facilitating personalized disease management and preventive interventions. By harnessing the power of technology and patient engagement, stakeholders in the urolithiasis management devices market can optimize healthcare delivery, improve patient satisfaction, and reduce overall healthcare costs.

Key Questions Addressed in the Report:

  • Which regions are expected to drive the growth of the urolithiasis management devices market in the coming years?
  • What are the primary factors driving the adoption of urolithiasis management devices and technologies?
  • How will evolving treatment guidelines and technological advancements influence market dynamics?
  • Who are the key players shaping the competitive landscape of the urolithiasis management devices market?
  • What strategies are market participants employing to gain a competitive edge and expand their market presence?

Competitive Landscape and Business Strategies:

Major players in the global urolithiasis management devices market, including Olympus Corporation, Boston Scientific Corporation, and Cook Medical LLC, prioritize innovation and strategic partnerships to maintain their market leadership. These companies invest heavily in research and development to develop next-generation urolithiasis management devices with enhanced efficacy, safety, and patient comfort. Moreover, strategic collaborations with healthcare providers and academic institutions enable market players to conduct clinical trials, validate product performance, and generate real-world evidence supporting the adoption of their devices. By focusing on product innovation, clinical evidence generation, and market expansion initiatives, leading players can capitalize on emerging opportunities and address unmet needs in the urolithiasis management devices market.

Key Companies Profiled:

  • Allengers
  • Boston Scientific
  • BD
  • Cook Medical
  • ConMed
  • DirexGroup
  • Dornier MedTech
  • KARL STORZ
  • Potent Optotronic
  • HealthTronics
  • Lumenis
  • Olympus
  • Richard Wolf
  • Siemens Healthcare

Urolithiasis Management Devices Market Segmentation:

By Treatment Type:

  • Extracorporeal Shock Wave Lithotripsy (ESWL)
  • Percutaneous Nephrolithotomy
  • Intracorporeal Lithotripsy
  • Others

By Product Type:

  • Lithotripters
  • Ureteroscopes

By End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Urolithiasis Management Devices Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Treatment Type Lifecycle Analysis
  • 2.4. Urolithiasis Management Devices Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global Urolithiasis Management Devices Market Outlook: Treatment Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
      • 3.3.3.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
      • 3.3.3.2. Percutaneous Nephrolithotomy
      • 3.3.3.3. Intracorporeal Lithotripsy
      • 3.3.3.4. Others
  • 3.4. Market Attractiveness Analysis: Treatment Type
  • 3.5. Global Urolithiasis Management Devices Market Outlook: Product Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
      • 3.5.3.1. Lithotripters
      • 3.5.3.2. Ureteroscopes
  • 3.6. Market Attractiveness Analysis: Product Type
  • 3.7. Global Urolithiasis Management Devices Market Outlook: End User
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.7.3.1. Hospitals and Clinics
      • 3.7.3.2. Ambulatory Surgical Centers (ASCs)
  • 3.8. Market Attractiveness Analysis: End User

4. Global Urolithiasis Management Devices Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Treatment Type
    • 5.3.3. By Product Type
    • 5.3.4. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
    • 5.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 5.5.2. Percutaneous Nephrolithotomy
    • 5.5.3. Intracorporeal Lithotripsy
    • 5.5.4. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 5.6.1. Mechanical
    • 5.6.2. Ureteroscopes
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.7.1. Hospitals and Clinics
    • 5.7.2. Ambulatory Surgical Centers (ASCs)
  • 5.8. Market Attractiveness Analysis

6. Europe Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Treatment Type
    • 6.3.3. By Product Type
    • 6.3.4. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. T rkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
    • 6.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 6.5.2. Percutaneous Nephrolithotomy
    • 6.5.3. Intracorporeal Lithotripsy
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 6.6.1. Mechanical
    • 6.6.2. Ureteroscopes
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.7.1. Hospitals and Clinics
    • 6.7.2. Ambulatory Surgical Centers (ASCs)
  • 6.8. Market Attractiveness Analysis

7. East Asia Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Treatment Type
    • 7.3.3. By Product Type
    • 7.3.4. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
    • 7.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 7.5.2. Percutaneous Nephrolithotomy
    • 7.5.3. Intracorporeal Lithotripsy
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 7.6.1. Mechanical
    • 7.6.2. Ureteroscopes
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.7.1. Hospitals and Clinics
    • 7.7.2. Ambulatory Surgical Centers (ASCs)
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Treatment Type
    • 8.3.3. By Product Type
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
    • 8.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 8.5.2. Percutaneous Nephrolithotomy
    • 8.5.3. Intracorporeal Lithotripsy
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 8.6.1. Mechanical
    • 8.6.2. Ureteroscopes
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.7.1. Hospitals and Clinics
    • 8.7.2. Ambulatory Surgical Centers (ASCs)
  • 8.8. Market Attractiveness Analysis

9. Latin America Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Treatment Type
    • 9.3.3. By Product Type
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
    • 9.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 9.5.2. Percutaneous Nephrolithotomy
    • 9.5.3. Intracorporeal Lithotripsy
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 9.6.1. Mechanical
    • 9.6.2. Ureteroscopes
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.7.1. Hospitals and Clinics
    • 9.7.2. Ambulatory Surgical Centers (ASCs)
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Treatment Type
    • 10.3.3. By Product Type
    • 10.3.4. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
    • 10.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 10.5.2. Percutaneous Nephrolithotomy
    • 10.5.3. Intracorporeal Lithotripsy
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 10.6.1. Mechanical
    • 10.6.2. Ureteroscopes
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.7.1. Hospitals and Clinics
    • 10.7.2. Ambulatory Surgical Centers (ASCs)
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Allengers
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Boston Scientific
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. BD
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Cook Medical
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. ConMed
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. DirexGroup
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Dornier MedTech
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. KARL STORZ
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Potent Optotronic
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. HealthTronics
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. Lumenis
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. Olympus
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Richard Wolf
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. Siemens Healthcare
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations